Search by Drug Name or NDC

NDC 16729-0267-64 DOCETAXEL 20 mg/mL Details

DOCETAXEL 20 mg/mL

DOCETAXEL is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is DOCETAXEL ANHYDROUS.

MedlinePlus Drug Summary

Docetaxel injection is used alone or in combination with other medications to treat certain types of breast, lung, prostate, stomach, and head and neck cancers. Docetaxel injection is in a class of medications called taxanes. It works by stopping the growth and spread of cancer cells.

Related Packages: 16729-0267-64
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Docetaxel Injection

Product Information

NDC	16729-0267
Product ID	16729-267_05d9fc19-1a14-cea7-e063-6394a90a52d3
Associated GPIs	21500005001310 21500005001315 21500005001317
GCN Sequence Number	066750
GCN Sequence Number Description	docetaxel VIAL 20MG/ML(1) INTRAVEN
HIC3	V1F
HIC3 Description	ANTINEOPLASTICS,MISCELLANEOUS
GCN	28663
HICL Sequence Number	010280
HICL Sequence Number Description	DOCETAXEL
Brand/Generic	Generic
Proprietary Name	DOCETAXEL
Proprietary Name Suffix	n/a
Non-Proprietary Name	docetaxel
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION, CONCENTRATE
Route	INTRAVENOUS
Active Ingredient Strength	20
Active Ingredient Units	mg/mL
Substance Name	DOCETAXEL ANHYDROUS
Labeler Name	Accord Healthcare Inc.
Pharmaceutical Class	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA201195
Listing Certified Through	2024-12-31

Package

NDC 16729-0267-64 (16729026764)

Pricing Information	N/A
NDC Package Code	16729-267-64
Billing NDC	16729026764
Package	1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-64) / 4 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2013-08-02
NDC Exclude Flag	N